Hi there,

The media can be the greatest force for peace on Earth. Instead, all too often, it’s wielded as a weapon of war. That's why we have to take the media back. Thanks to a group of generous donors, all donations made today will be DOUBLED, which means your $15 gift is worth $30. With your contribution, we can continue to go to where the silence is, to bring you the voices of the silenced majority – those calling for peace in a time of war, demanding action on the climate catastrophe and advocating for racial and economic justice. Every dollar makes a difference. Thank you so much!

Democracy Now!
Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Rep. Tauzin To Quit To Take Drug Lobbying Job

HeadlineFeb 04, 2004

Republican Congressman W.J. “Billy” Tauzin of Louisiana has announced he will not seek a 13th term in office and will vacate the chairmanship of the Energy and Commerce Committee effective Feb. 16. Tauzin is expected to take a job heading the lobbying giant Pharmaceutical Research and Manufacturers of America, which is the trade group that represents drug giants including Pfizer and Merck & Co. Tauzin was one of the principal authors of the Medicare prescription drug bill, which included several provisions expected to vastly expand the market for prescription drugs among the elderly. In addition the Washington Post reports the law bars the federal government from directly bargaining down the price of drugs, a provision the pharmaceutical lobby called for.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top